Page last updated: 2024-10-29

ketamine and Hypoalbuminemia

ketamine has been researched along with Hypoalbuminemia in 1 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Hypoalbuminemia: A condition in which albumin level in blood (SERUM ALBUMIN) is below the normal range. Hypoalbuminemia may be due to decreased hepatic albumin synthesis, increased albumin catabolism, altered albumin distribution, or albumin loss through the urine (ALBUMINURIA).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Saad, M1
Le Clec'h, B1
Dhonneur, G1

Other Studies

1 other study available for ketamine and Hypoalbuminemia

ArticleYear
Hypoalbuminemia-Related Prolonged Sedation After General Anesthesia: A Case Report.
    A&A practice, 2020, Volume: 14, Issue:6

    Topics: Aged; Anesthesia, General; Anesthetics, Intravenous; Free Tissue Flaps; Humans; Hypoalbuminemia; Hyp

2020